News & Events

Company & Partner News

Dec 05, 2019

Iscalimab Update

View Press Release Learn More

CEO Letter – First Half 2019

XOMA Congratulates Rezolute on its Successful Financing and Progress Towards Initiating Phase 2b Study for RZ358

XOMA Congratulates Sesen Bio on Successful Pre-BLA Meeting with FDA for Vicinium

Latest News

Dec 20, 2019 • 4:35 PM EST

XOMA Announces Closing of Rights Offering

Dec 5, 2019 • 5:04 PM EST

Iscalimab (CFZ533) Update

Dec 2, 2019 • 4:30 PM EST

XOMA Announces Commencement of Rights Offering

View All Press Releases

Corporate Presentation

View Presentation